NCT06456489

Pulse Steroid Injection in Refractory Rheumatoid Arthritis

Revealing the Potential of Intravenous Pulse Steroid Therapy; Impressive Results in Attaining Remission or Low Disease Activity in Refractory Rheumatoid Arthritis

• Status: Recruiting
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 268 (estimated)
• Sponsor: Sohag University · Academic / Other
• Sex: All
• Age: 20 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

Remission or low disease activity in active rheumatoid arthritis

Detailed description

Assessment of rheumatoid arthritis activity by Disease activity score DAS28, DAS28 Erythrocyte sedimentation rate (ESR), American college of rheumatology (ACR) 20, ACR 50, ACR 70 will be done at baseline and every month for 3 consecutive months for both groups.

Conditions

• Active Rheumatoid Arthritis

Interventions

Type	Name	Description
DRUG	Solumedrol	125 mg methylprednisolone intravenous pulse on 2 consecutive days

Timeline

• Start date: 2024-05-01
• Primary completion: 2024-09-30
• Completion: 2024-12-31
• First posted: 2024-06-13
• Last updated: 2024-06-13

Locations

1 site across 1 country: Egypt